Presented by Alliance for Aging Research {beacon} Health Care Health Care PRESENTED BY The Big Story Vaccine advisers to ...

Additional evidence supports current guideline recommendations to treat all who are hospitalized with influenza with an ...

ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A H5N1 Quantitative Stock, a groundbreaking advancement ...

Cidara Therapeutics' shares were set to rally at the opening bell after a trial of the biotechnology company's non-vaccine preventative of seasonal influenza met all key goals. In premarket trading, ...

In a study of newborn piglets, infection with influenza A was associated with disruptions in the piglets' nasal and gut ...

MSD's Enflonsia (clesrovimab) has received US Food and Drug Administration (FDA) approval for the prevention of respiratory ...

A $2 upgrade to protective packaging that prevents 5% damage on a $94 case of eggs saves $4.70 per case, compared to $1 ...

Individuals currently suffering from respiratory illnesses are more likely to be infected with influenza or COVID-19, the two ...

The approval was based on data from the pivotal Phase IIb/III CLEVER trial which assessed a single dose of the antibody.

Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

The latest edition of Poultry World is available online. In this edition we visit a former investment banker who had built a ...

For the first time since the start of the COVID-19 pandemic, the number of Nova Scotians dying from influenza exceeds that of ...